AQR Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

AQR Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,387	Closed	-$392K	–	2343
2018 Q2	$392K	Sell	3,387 -3,656	-52%	-$402K	﹤0.01%	2051
2018 Q1	$695K	Sell	7,043 -6,041	-46%	-$612K	﹤0.01%	1802
2017 Q4	$1.37M	Hold	13,084	–	–	﹤0.01%	1546
2017 Q3	$1.47M	Hold	13,084	–	–	﹤0.01%	1508
2017 Q2	$1.47M	Sell	13,084 -522	-4%	-$59K	﹤0.01%	1521
2017 Q1	$1.59M	Buy	13,606 +3,649	+37%	+$404K	﹤0.01%	1482
2016 Q4	$1.05M	Buy	9,957 +5,494	+123%	+$575K	﹤0.01%	1676
2016 Q3	$493K	Sell	4,463 -391	-8%	-$51.8K	﹤0.01%	1943
2016 Q2	$707K	Buy	4,854 +826	+21%	+$117K	﹤0.01%	1738
2016 Q1	$577K	Buy	+4,028	New	+$572K	﹤0.01%	1784

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

AQR Capital Management's TARO Position: Q3 2018 in Review

AQR Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2018, closing a stake of 3,387 shares — an estimated $392K sold.

AQR Capital Management first reported a position in TARO in Q1 2016 and held it in 10 quarters. The position peaked at $1.59M in Q1 2017. 114 funds tracked by Wall St. Rank hold TARO as of Q3 2018.

AQR Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2018 after selling out during the quarter.
AQR Capital Management sold 3,387 Taro Pharmaceutical Industries Ltd. shares in Q3 2018, an estimated $392K.
AQR Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 10 quarters.
AQR Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $1.59M in Q1 2017.
114 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2018.

Based on AQR Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.